IL133201A0 - Lowering blood levels of lipoproten (a) - Google Patents

Lowering blood levels of lipoproten (a)

Info

Publication number
IL133201A0
IL133201A0 IL13320199A IL13320199A IL133201A0 IL 133201 A0 IL133201 A0 IL 133201A0 IL 13320199 A IL13320199 A IL 13320199A IL 13320199 A IL13320199 A IL 13320199A IL 133201 A0 IL133201 A0 IL 133201A0
Authority
IL
Israel
Prior art keywords
lipoproten
blood levels
lowering blood
lowering
levels
Prior art date
Application number
IL13320199A
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of IL133201A0 publication Critical patent/IL133201A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL13320199A 1998-12-04 1999-11-29 Lowering blood levels of lipoproten (a) IL133201A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11110098P 1998-12-04 1998-12-04

Publications (1)

Publication Number Publication Date
IL133201A0 true IL133201A0 (en) 2001-03-19

Family

ID=22336605

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13320199A IL133201A0 (en) 1998-12-04 1999-11-29 Lowering blood levels of lipoproten (a)

Country Status (6)

Country Link
JP (1) JP2000169395A (en)
KR (1) KR20000047857A (en)
CA (1) CA2291471A1 (en)
HU (1) HUP9904485A3 (en)
IL (1) IL133201A0 (en)
ZA (1) ZA997446B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2324801A1 (en) * 1999-11-10 2001-05-10 Andrew Gordon Swick Use of apo b secretion/mtp inhibitors and anti-obesity agents
IL139449A0 (en) * 1999-11-10 2001-11-25 Pfizer Prod Inc Use of apo b secretion/mtp inhibitors
CA2324800A1 (en) * 1999-11-10 2001-05-10 Mary Anne Hickman Use of apo b secretion/mtp inhibitors
IL139450A0 (en) * 1999-11-10 2001-11-25 Pfizer Prod Inc Methods of administering apo b-secretion/mtp inhibitors
CN101838218A (en) 2002-02-28 2010-09-22 日本烟草产业株式会社 Ester compound and pharmaceutical use of the same
WO2005021486A1 (en) 2003-08-29 2005-03-10 Japan Tobacco Inc. Ester derivative and medicinal use thereof
CA2910191C (en) 2004-03-05 2022-03-08 The Trustees Of The Univeristy Of Pennsylvania The use of mtp inhibitors for treating disorders or diseases associated with hyperlipidemia and hypercholesterolemia while minimizing side effects
US8101774B2 (en) 2004-10-18 2012-01-24 Japan Tobacco Inc. Ester derivatives and medicinal use thereof
CA3186856A1 (en) 2020-07-29 2022-02-03 Ruth NALLEN Lomitapide for use in methods of treating hyperlipidemia and hypercholesterolemia in pediatric patients

Also Published As

Publication number Publication date
HUP9904485A3 (en) 2000-09-28
KR20000047857A (en) 2000-07-25
ZA997446B (en) 2001-06-04
HUP9904485A2 (en) 2000-08-28
HU9904485D0 (en) 2000-02-28
JP2000169395A (en) 2000-06-20
CA2291471A1 (en) 2000-06-04

Similar Documents

Publication Publication Date Title
HUP0103526A3 (en) Catheter set
GB2344283B (en) Patient support
AU142196S (en) Tissue
GB9811116D0 (en) Method of altering heartbeat
GB9802599D0 (en) Medical use
AU142195S (en) Tissue
IL133201A0 (en) Lowering blood levels of lipoproten (a)
GB2341104B (en) A medical electrode
AU137972S (en) Implant
AU142197S (en) Tissue
GB2336779B (en) External Catheter
AU140956S (en) Tissue
GB9820804D0 (en) ANSI syringe
GB9824518D0 (en) Patient movement aid
TW344214U (en) Improved structure of a fryer
GB9828012D0 (en) Surgical arterial plug
GB9817916D0 (en) Arterial cannula
TW409704U (en) Structure of hermetic can
TW435201U (en) Improved structure of stethoscope
AUPP552098A0 (en) Patient hoist
GB9815149D0 (en) Treatment of diabetes
GB9812314D0 (en) Treatment of diabetes
GB9814241D0 (en) Medical implants
TW357555U (en) Patient trousures
GB9805594D0 (en) Physiological supports